Abstracts by keywords: healthcare system
The development in health care includes the implementation of contracts between different players as one of the main regulating factors. Contracts don't run by themselves; it's not enough to agree on content and sign it. The evaluation must be taken into account and planned as early as when the contract is concluded, and not only after 3 years, but continuously and concomitantly. The appropriate source for the information, as well as the type and amount of information required, depends on the type of contract and the content of the contract. In order to consider selective contracts with doctors or groups, data and evaluations from random samples of relevant size, which also allow regionally valid considerations and extrapolations, are required. Evaluations from billing data are not sufficient here because they do not adequately reflect medical behavior.
23.09.2012
Since the legislator activated the option of drug discount contracts in the GKV Competition Strengthening Act (April 2007), corresponding discount contracts in the generic market segment have developed into a successful model. On the other hand, the objections repeatedly raised by interested parties, in particular pharmaceutical companies, with regard to patient compliance or alleged market share losses of pharmaceutical SMEs, stand up to neither public opinion nor empirical scrutiny. Discount agreements form an efficient and forward-looking competitive instrument between statutory health insurance companies and the pharmaceutical industry.